Sirnaomics Ltd. (HK:2257) has released an update.
Sirnaomics Ltd., a company focused on RNAi therapeutics, has outlined its board of directors, featuring a blend of executive, non-executive, and independent members. Key figures include Dr. Poon Hung Fai as CEO and Dr. Yang Lu as Chairman. The board is supported by three committees, emphasizing the company’s structured governance.
For further insights into HK:2257 stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- No Resolution Between Paramount Global (NASDAQ:PARA) and Nielsen
- Ford (NYSE:F) Enters Mustang Mach-E in Road Rally
- Concerns Growing Over Intel (NASDAQ:INTC) Battlemage Line
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
